AR002009A1 - Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. - Google Patents
Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.Info
- Publication number
- AR002009A1 AR002009A1 ARP950100614A AR10061495A AR002009A1 AR 002009 A1 AR002009 A1 AR 002009A1 AR P950100614 A ARP950100614 A AR P950100614A AR 10061495 A AR10061495 A AR 10061495A AR 002009 A1 AR002009 A1 AR 002009A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- composition
- pharmaceutical composition
- procedure
- powder
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 4
- 150000002632 lipids Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000007704 transition Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composición farmacéutica que comprende un polvo de proliposoma, comprendiendo dicho polvo, en una única fase, partículas discretas de uncomponente biológicamente activo junto con un lípido o mezcla de lípidos que tiene una temperaturade transición de fase por debajo de 37°C y un portadorcristalino e hidrofílico farmacéuticamente aceptable. Además, se dan a conocer un procedimiento para la manufactura de un polvo de proliposoma como elutilizado en dicha composición farmacéutica,un procedimiento para la manufactura de dicha composición farmacéutica, el uso de dicha composiciónfarmacéutica en la manufactura de un medicamento y un dispositivo inhalador de polvo seco.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9404466A SE9404466D0 (sv) | 1994-12-22 | 1994-12-22 | Process for the preparation of powders for inhalation |
| SE9502369A SE9502369D0 (sv) | 1995-06-30 | 1995-06-30 | Process for the preparation of compositions for inhalation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002009A1 true AR002009A1 (es) | 1998-01-07 |
Family
ID=26662194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP950100614A AR002009A1 (es) | 1994-12-22 | 1995-12-18 | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6045828A (es) |
| EP (1) | EP0800383B1 (es) |
| JP (1) | JPH10510830A (es) |
| KR (1) | KR100432461B1 (es) |
| CN (1) | CN1087932C (es) |
| AR (1) | AR002009A1 (es) |
| AT (1) | ATE240095T1 (es) |
| AU (1) | AU693632B2 (es) |
| BR (1) | BR9510512A (es) |
| CA (1) | CA2208517A1 (es) |
| CZ (1) | CZ286469B6 (es) |
| DE (1) | DE69530792T2 (es) |
| DK (1) | DK0800383T3 (es) |
| EE (1) | EE03592B1 (es) |
| EG (1) | EG23683A (es) |
| ES (1) | ES2194931T3 (es) |
| FI (1) | FI972653A7 (es) |
| HU (1) | HUT77628A (es) |
| IL (1) | IL116454A (es) |
| IS (1) | IS1978B (es) |
| MY (1) | MY114114A (es) |
| NO (1) | NO320434B1 (es) |
| NZ (1) | NZ298180A (es) |
| PL (1) | PL184393B1 (es) |
| PT (1) | PT800383E (es) |
| RU (1) | RU2162689C2 (es) |
| SA (1) | SA95160463B1 (es) |
| SK (1) | SK284918B6 (es) |
| TR (1) | TR199501633A1 (es) |
| TW (1) | TW508248B (es) |
| UA (1) | UA43886C2 (es) |
| WO (1) | WO1996019199A1 (es) |
Families Citing this family (111)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA95160463B1 (ar) * | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
| US20020052310A1 (en) * | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
| TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
| AU4424797A (en) * | 1996-09-18 | 1998-04-14 | Dragoco Inc. | Liposome encapsulated active agent dry powder composition |
| US20030203036A1 (en) * | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
| WO1999000111A1 (en) * | 1997-06-27 | 1999-01-07 | Astra Aktiebolag (Publ) | Proliposome powders for inhalation stabilised by tocopherol |
| IL133597A0 (en) * | 1997-06-27 | 2001-04-30 | Astra Ab | New combination of antiasthma medicaments |
| US7052678B2 (en) * | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6090407A (en) | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
| US7348025B2 (en) | 1997-09-23 | 2008-03-25 | Research Development Foundation | Small particle liposome aerosols for delivery of anticancer drugs |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
| US6946117B1 (en) | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| SE9704833D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New formulation |
| US6956021B1 (en) * | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| EP1839648A3 (en) * | 1998-11-12 | 2007-11-21 | Transave, Inc. | An inhalation system |
| JP2002529393A (ja) * | 1998-11-12 | 2002-09-10 | フランク ジー． ピルキーウィッツ， | 吸入システム |
| GB9912639D0 (en) | 1999-05-28 | 1999-07-28 | Britannia Pharmaceuticals Ltd | Improvements in and relating to treatment of respiratory conditions |
| EP1133301A1 (en) * | 1998-11-26 | 2001-09-19 | Britannia Pharmaceuticals Limited | Anti-asthmatic combinations comprising surface active phospholipids |
| BR9917246A (pt) * | 1999-03-05 | 2002-03-26 | Chiesi Farma Spa | Composições farmacêuticas avançadas em pó para inalação |
| EP1043016B1 (en) * | 1999-03-30 | 2014-08-20 | Sodic Sa | A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same |
| DE60026982T2 (de) * | 1999-04-05 | 2006-11-16 | Mannkind Corp., Danbury | Verfahren zur bildung von feinem pulver |
| US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| PT1180017E (pt) | 1999-05-27 | 2010-05-28 | Euro Celtique Sa | Preparações com povidona-iodo para o tratamento de feridas |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
| US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
| WO2001013891A2 (en) * | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
| US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| GB9928311D0 (en) * | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
| DE10012151A1 (de) * | 2000-03-13 | 2001-09-27 | Gsf Forschungszentrum Umwelt | Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| DK1280520T4 (en) | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| ATE416184T1 (de) | 2000-08-05 | 2008-12-15 | Glaxo Group Ltd | 17.beta.-carbothioat 17.alpha.- arylkarbonyloxyloxy androstanderivate als anti- phlogistische medikamente |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| PT2283817T (pt) | 2000-11-30 | 2016-08-22 | Vectura Ltd | Método de fabrico de partículas para utilização numa composição farmacêutica |
| US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| WO2002088167A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| JP4368198B2 (ja) * | 2001-11-20 | 2009-11-18 | アルカーメス，インコーポレイテッド | 肺送達用の改良された粒状組成物 |
| SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
| NZ534142A (en) * | 2002-01-21 | 2007-08-31 | Vasogen Ireland Ltd | Pharmaceutically acceptable phosphate-glycerol carrying bodies comprising phospatidylglycerol and/or phosphatidylcholine and/or phosphatidylglycerol |
| AU2003230600B2 (en) * | 2002-03-05 | 2009-06-04 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
| PT1494732E (pt) | 2002-03-20 | 2008-03-20 | Mannkind Corp | Aparelho de inalação |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| NZ540087A (en) * | 2002-10-29 | 2008-09-26 | Transave Inc | Sustained release of antiinfectives |
| CN1208052C (zh) | 2003-03-20 | 2005-06-29 | 上海家化联合股份有限公司 | 一种辅酶q10前体脂质体及其制备方法 |
| US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
| AU2004231342A1 (en) | 2003-04-14 | 2004-11-04 | Vectura Ltd | Dry power inhaler devices and dry power formulations for enhancing dosing efficiency |
| US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
| CN100427064C (zh) * | 2003-04-16 | 2008-10-22 | 沈阳药科大学 | 一种制备脂质体的新方法 |
| DK1699434T3 (da) * | 2003-09-02 | 2011-05-30 | Norton Healthcare Ltd | Fremgangsmåde til fremstilling af et lægemiddel |
| US20050214224A1 (en) * | 2003-11-04 | 2005-09-29 | Nektar Therapeutics | Lipid formulations for spontaneous drug encapsulation |
| MX2007001903A (es) | 2004-08-20 | 2007-08-02 | Mannkind Corp | Catalisis de sintesis de dicetopiperazina. |
| KR20130066695A (ko) | 2004-08-23 | 2013-06-20 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| KR101486397B1 (ko) | 2005-09-14 | 2015-01-28 | 맨카인드 코포레이션 | 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법 |
| ES2594368T3 (es) | 2005-12-08 | 2016-12-19 | Insmed Incorporated | Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares |
| BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
| CN1895223B (zh) * | 2006-04-05 | 2012-06-27 | 沈阳药科大学 | 一种新的脂质体制备方法 |
| US9814672B2 (en) * | 2007-03-09 | 2017-11-14 | Susan T. Laing | Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi |
| EP2146692A1 (en) * | 2007-03-19 | 2010-01-27 | Fresenius Kabi Oncology Limited | Proliposomal and liposomal compositions |
| US20100196455A1 (en) * | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
| US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
| US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
| US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
| US20090047336A1 (en) * | 2007-08-17 | 2009-02-19 | Hong Kong Baptist University | novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
| US8485180B2 (en) * | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| US9358352B2 (en) | 2008-06-13 | 2016-06-07 | Mannkind Corporation | Dry powder drug delivery system and methods |
| RU2608439C2 (ru) * | 2008-06-13 | 2017-01-18 | Маннкайнд Корпорейшн | Ингалятор для сухого порошка и система для доставки лекарственных средств |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| EP4403231A3 (en) | 2009-02-26 | 2024-10-23 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| EP2676695A3 (en) | 2009-03-11 | 2017-03-01 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| CN102647979B (zh) | 2009-06-12 | 2015-03-04 | 曼金德公司 | 具有确定比表面积的二酮哌嗪颗粒 |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| WO2013063160A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
| NZ719739A (en) | 2012-05-21 | 2017-07-28 | Insmed Inc | Systems for treating pulmonary infections |
| CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| EA035868B1 (ru) | 2012-08-17 | 2020-08-24 | Смартек Интернэшнл Эл-Эл-Си | Приготовление высушенных липосом для применения в системах выпуска в прессованном виде |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| ES2743039T3 (es) | 2012-11-29 | 2020-02-18 | Insmed Inc | Formulaciones de vancomicina estabilizada |
| US9603799B2 (en) * | 2013-03-15 | 2017-03-28 | Htd Biosystems Inc. | Liposomal vaccine adjuvants and methods of making and using same |
| EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
| CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| ES2926985T3 (es) | 2014-05-15 | 2022-10-31 | Insmed Inc | Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| JP7066632B2 (ja) * | 2016-05-09 | 2022-05-13 | アストラゼネカ・アクチエボラーグ | 親油性抗炎症剤を含む脂質ナノ粒子およびその使用方法 |
| BR112020007083A2 (pt) * | 2017-10-11 | 2020-09-24 | Bast Biotechnology | composições e métodos para tratamento de fibrose |
| EP3773505A4 (en) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS |
| CA3098573A1 (en) | 2018-05-02 | 2019-11-07 | Insmed Incorporated | Methods for the manufacture of liposomal drug formulations |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US514674A (en) * | 1894-02-13 | Ejector for breakdown guns | ||
| DE2966795D1 (en) * | 1978-10-12 | 1984-04-19 | Bowater Scott Ltd | Holder and dispenser for stacked rolls |
| GB2135647A (en) * | 1983-02-15 | 1984-09-05 | Squibb & Sons Inc | Method of preparing liposomes and products produced thereby |
| US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
| DE3585967D1 (de) * | 1984-03-08 | 1992-06-11 | Phares Pharma Holland | Liposombildende zusammensetzung. |
| SE8601457D0 (sv) * | 1986-04-01 | 1986-04-01 | Draco Ab | Compositions of liposomes and b?712-receptor active substances for inhalation |
| SE8603812D0 (sv) * | 1986-09-12 | 1986-09-12 | Draco Ab | Administration of liposomes to mammals |
| US5096629A (en) * | 1988-08-29 | 1992-03-17 | 501 Nippon Fine Chemical Co., Ltd. | Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes |
| RU2014071C1 (ru) * | 1991-03-26 | 1994-06-15 | Научно-производственный центр медицинской биотехнологии | Способ получения липосом, содержащих водорастворимые низкомолекулярные соединения |
| CA2087902C (en) * | 1992-02-05 | 2006-10-17 | Narendra Raghunathji Desai | Liposome compositions of porphyrin photosensitizers |
| JPH09501168A (ja) * | 1993-08-06 | 1997-02-04 | オパーバス ホールディング ビー ヴィ | 生物構造体、生体ポリマー及び／又はオリゴマーを充填した小胞の調製方法 |
| US5635206A (en) * | 1994-01-20 | 1997-06-03 | Hoffmann-La Roche Inc. | Process for liposomes or proliposomes |
| SA95160463B1 (ar) * | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
-
1995
- 1995-12-18 SA SA95160463A patent/SA95160463B1/ar unknown
- 1995-12-18 AR ARP950100614A patent/AR002009A1/es unknown
- 1995-12-19 IL IL11645495A patent/IL116454A/en not_active IP Right Cessation
- 1995-12-19 TW TW084113555A patent/TW508248B/zh not_active IP Right Cessation
- 1995-12-20 EE EE9700134A patent/EE03592B1/xx not_active IP Right Cessation
- 1995-12-20 DE DE69530792T patent/DE69530792T2/de not_active Expired - Lifetime
- 1995-12-20 HU HU9800352A patent/HUT77628A/hu unknown
- 1995-12-20 NZ NZ298180A patent/NZ298180A/xx unknown
- 1995-12-20 CN CN95196978A patent/CN1087932C/zh not_active Expired - Fee Related
- 1995-12-20 DK DK95942357T patent/DK0800383T3/da active
- 1995-12-20 CZ CZ19971948A patent/CZ286469B6/cs not_active IP Right Cessation
- 1995-12-20 UA UA97073873A patent/UA43886C2/uk unknown
- 1995-12-20 KR KR1019970704253A patent/KR100432461B1/ko not_active Expired - Fee Related
- 1995-12-20 CA CA002208517A patent/CA2208517A1/en not_active Abandoned
- 1995-12-20 AT AT95942357T patent/ATE240095T1/de not_active IP Right Cessation
- 1995-12-20 BR BR9510512A patent/BR9510512A/pt not_active IP Right Cessation
- 1995-12-20 MY MYPI95003994A patent/MY114114A/en unknown
- 1995-12-20 RU RU97112399/14A patent/RU2162689C2/ru not_active IP Right Cessation
- 1995-12-20 FI FI972653A patent/FI972653A7/fi not_active Application Discontinuation
- 1995-12-20 PL PL95320825A patent/PL184393B1/pl not_active IP Right Cessation
- 1995-12-20 ES ES95942357T patent/ES2194931T3/es not_active Expired - Lifetime
- 1995-12-20 US US08/617,918 patent/US6045828A/en not_active Expired - Lifetime
- 1995-12-20 SK SK814-97A patent/SK284918B6/sk unknown
- 1995-12-20 EP EP95942357A patent/EP0800383B1/en not_active Expired - Lifetime
- 1995-12-20 JP JP8519738A patent/JPH10510830A/ja not_active Ceased
- 1995-12-20 PT PT95942357T patent/PT800383E/pt unknown
- 1995-12-20 WO PCT/SE1995/001560 patent/WO1996019199A1/en not_active Ceased
- 1995-12-20 AU AU43605/96A patent/AU693632B2/en not_active Ceased
- 1995-12-21 EG EG106095A patent/EG23683A/xx active
- 1995-12-21 TR TR95/01633A patent/TR199501633A1/xx unknown
-
1997
- 1997-06-06 IS IS4500A patent/IS1978B/is unknown
- 1997-06-19 NO NO19972847A patent/NO320434B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR002009A1 (es) | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. | |
| ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
| AR011080A1 (es) | Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento | |
| AU7792987A (en) | Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof | |
| AR017979A1 (es) | Formulaciones farmaceuticas de epotilonas, metodo para su preparacion y el uso de los mismos para la manufactura de un medicamento | |
| ES2036457A1 (es) | Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion. | |
| UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| AR002754A1 (es) | Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento | |
| CL2004001191A1 (es) | Compuestos derivados de esteroides 17 alpha-fluoroalquilados, con actividad antigestagena; composicion farmaceutica; combinacion farmaceutica; y uso del compuesto en la preparacion de un medicamento antiestrogenico, para el tratamiento de dismenorrea | |
| AR035500A1 (es) | Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina. | |
| DK0607118T3 (da) | System til administrering af phospholipid | |
| DE69828817D1 (de) | Pharmazeutische aerosolzusammensetzungen | |
| AR018582A1 (es) | Forma de dosificacion en tableta para administrar un antagonista de los receptores de los leucotrienos y su uso en la preparacion de medicamentos | |
| EE04273B1 (et) | Bensotsüklohepteenid, nende valmistamise meetod, neid sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks | |
| ES2067250T5 (es) | Preparado farmaceutico sin disolventes para administracion oral, con liberacion retardada de la sustancia activa y procedimiento para su fabricacion. | |
| DE69602759D1 (de) | Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung | |
| SE9704400D0 (sv) | Porous inorganic particles as carriers for drug substances | |
| DE59811768D1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
| ATE87467T1 (de) | Pharmazeutische zubereitung. | |
| AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
| AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
| DE59607949D1 (de) | Feste arzneimittelform mit polymerem material verteiltem wirkstoff | |
| FI960740A0 (fi) | Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi, niiden käyttö farmaseuttisten valmisteiden valmistukseen ja niitä sisältäviä lääkkeitä | |
| PT742716E (pt) | Composicao farmaceutica para administracao transdermica sistemica contendo a substancia activa morfina-6-glucuronido |